STOCK TITAN

ZSAN (ZSAN) Stock Price, News & Analysis

ZSAN NASDAQ

Company Description

ZSAN (NASDAQ: ZSAN) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $2.7M.

This page collects what Stock Titan holds for ZSAN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-
Performance 1 year

Latest News

ZSAN has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include earnings, stock split, offering, clinical trial, management. View all ZSAN news →

SEC Filings

No SEC filings available for ZSAN.

Financial Highlights

Revenue (latest FY)
Net Income (latest FY)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ZSAN Company Profile & Sector Positioning

ZSAN (ZSAN) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing ZSAN often look at related companies in the same sector, including Lipella Pharmaceuticals Inc (LIPO), Salarius Pharmaceuticals Inc (SLRX), Gt Biopharma Inc (GTBP), Protagenic Therapeutics Inc (PTIX), and Virax Biolabs Group Ltd (VRAX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ZSAN's relative position within its industry.

Frequently Asked Questions

What is the market cap of ZSAN (ZSAN)?

The market cap of ZSAN (ZSAN) is approximately 2.7M. Learn more about what market capitalization means .